Diary - News
All news MaaT Pharma announces CE marking for its globally unique medical device
Lyon (France), June 15, 2017. A few days aftersigning a strategic partnership for the treatment of intestinal dysbiosis by FMT (Fecal Microbiota Transfer), MaaT Pharma pursues its industrialization process with the CE marking of the first ever stool collection and dilution device.
The necessary standardization of a booming activity requiring challenging safety rules ... The international protocols established by teams who practice FMT vary according to the indications treated and are intended to minimize the risk of transmission of pathogens.
Read the press release
